Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRO: Macitentan in Eisenmenger Syndrome
NCT01743001Phase 3Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- May 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of macitentan in Eisenmenger syndrome, sponsored by Actelion Pharmaceuticals Ltd. Started May 2013; status: completed.
02
Drugs
macitentan
03
Conditions
Eisenmenger syndrome
Beyond the preview
Go deeper on NCT01743001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743001.